A judge will decide how much a Johnson & Johnson and a subsidiary must pay the state of Arkansas, after a jury found the company downplayed and hid risks associated with an antipsychotics drug. Jurors returned a quick verdict Tuesday in favor of the state, which had argued that Janssen Pharmaceuticals Inc. lied about potentially life-threatening side effects of Risperdal. Circuit Judge Tim Fox told lawyers he will read briefs and relevant cases they sent him before a hearing Wednesday to decide how much Johnson & Johnson and its subsidiary must pay.
